PA
CLOV icon

Perceptive Advisors’s Clover Health Investments CLOV Stock Holding History

Perceptive Advisors’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,500,000
Closed -$1.27M – 100
2023
Q1 		$1.27M Hold
1,500,000
– – 0.04% 92
2022
Q4 		$1.39M Hold
1,500,000
– – 0.04% 89
2022
Q3 		$2.55M Hold
1,500,000
– – 0.07% 97
2022
Q2 		$3.21M Hold
1,500,000
– – 0.1% 87
2022
Q1 		$5.33M Hold
1,500,000
– – 0.11% 102
2021
Q4 		$5.58M Hold
1,500,000
– – 0.09% 114
2021
Q3 		$11.1M Hold
1,500,000
– – 0.16% 96
2021
Q2 		$20M Hold
1,500,000
– – 0.26% 84
2021
Q1 		$10.3M Buy
+1,500,000
New +$16.9M 0.14% 98

Other funds holding CLOV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $7.09B AUM 21.48% 1-Year Est. Return